Valproic Acid I: Time Course of Lipid Peroxidation Biomarkers, Liver Toxicity, and Valproic Acid Metabolite Levels in Rats
Authors:
Open Access
- 27 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 86 (2) , 427-435
Abstract
A single dose of valproic acid (VPA), which is a widely used antiepileptic drug, is associated with oxidative stress in rats, as recently demonstrated by elevated levels of 15-F2t-isoprostane (15-F2t-IsoP). To determine whether there was a temporal relationship between VPA-associated oxidative stress and hepatotoxicity, adult male Sprague-Dawley rats were treated ip with VPA (500 mg/kg) or 0.9% saline (vehicle) once daily for 2, 4, 7, 10, or 14 days. Oxidative stress was assessed by determining plasma and liver levels of 15-F2t-IsoP, lipid hydroperoxides (LPO), and thiobarbituric acid reactive substances (TBARs). Plasma and liver 15-F2t-IsoP were elevated and reached a plateau after day 2 of VPA treatment compared to control. Liver LPO levels were not elevated until day 7 of treatment (1.8-fold versus control, p < 0.05). Liver and plasma TBARs were not increased until 14 days (2-fold vs. control, p < 0.05). Liver toxicity was evaluated based on serum levels of α-glutathione S-transferase (α-GST) and by histology. Serum α-GST levels were significantly elevated by day 4, which corresponded to hepatotoxicity as shown by the increasing incidence of inflammation of the liver capsule, necrosis, and steatosis throughout the study. The liver levels of β-oxidation metabolites of VPA were decreased by day 14, while the levels of 4-ene-VPA and (E)-2,4-diene-VPA were not elevated throughout the study. Overall, these findings indicate that VPA treatment results in oxidative stress, as measured by levels of 15-F2t-IsoP, which precedes the onset of necrosis, steatosis, and elevated levels of serum α-GST.Keywords
This publication has 36 references indexed in Scilit:
- Valproic acid glucuronidation is associated with increases in 15-F2t-isoprostane in ratsFree Radical Biology and Medicine, 2005
- Valproic Acid II: Effects on Oxidative Stress, Mitochondrial Membrane Potential, and Cytotoxicity in Glutathione-Depleted Rat HepatocytesToxicological Sciences, 2005
- Effect of Acute and Chronic Administration of Sodium Valproate on Lipid Peroxidation and Antioxidant System in Rat LiverBasic & Clinical Pharmacology & Toxicology, 1999
- α-glutathione s-transferase (α-GST) release, an early indicator of carbon tetrachloride hepatotoxicity in the ratHuman & Experimental Toxicology, 1997
- Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytesToxicology, 1996
- Fluorinated Analogs as Mechanistic Probes in Valproic Acid Hepatotoxicity: Hepatic Microvesicular Steatosis and Glutathione StatusChemical Research in Toxicology, 1995
- Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedicationEpilepsy Research, 1993
- Early Structural and Functional Changes in Liver of Rats Treated with a Single Dose of Valproic AcidHepatology, 1984
- Valproate–Induced Hepatic Steatogenesis in RatsHepatology, 1982
- Reye-like syndrome associated with valproic acid therapyThe Journal of Pediatrics, 1979